Piyush Parwal

1) The housing finance lender HDFC said that the month of September had seen the strongest recovery since the outbreak of the pandemic.2) TATA Motors - Tata Motors climbed up 8% to Rs144 amid hefty volumes of 9.7cr shares traded on NSE after the company announced strong growth its JLR sales volume on QoQ and positive free cash flow. The company says JLR’s cash and short-term deposits rose by 300 million pounds to about 3 billion pounds, primarily reflecting positive free cash flow for the three-month period. The company says its performance in China, the first region to come out of lockdown, has been incredibly encouraging.Mahindra & Mahindra- The company has informed the exchanges that booking for its latest SUV, 'Thar' has crossed 9,000, since its launch on October 2. #MOMArketUpdates #MotilalOswal #Indianstockmarket #nifty #sensex #TATAMotors #Mahindra #Thar #JLR

1) Apollo pipes had a bull run today. The company’s overall sales up 19% to 12,268 MT. Growth was driven by contribution from across product categories, including value-added product segment of fittings. The company anticipates further improvement in sales performance over the next few quarters on the back of a better demand environment combined with an uptick in utilisation levels. 2) Chinese steelmaker, Jingye has expressed an interest in taking over Tata Steel's UK operations, said a leading UK-based televison channel Sky News. “Banking sources said this weekend that Jingye’s interest was at a tentative stage, and insisted that there was not a formal sale process for Tata Steel UK’s operations,” #MOMarketUpdates #MotilalOswal #Indianstockmarkets #Nifty #sensex #tatasteel

1) Wockhardt said it had agreed with the UK government to fill-finish COVID-19 vaccines. The manufacturing will be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales. "As per the terms of the agreement, the company has reserved manufacturing capacity to allow for the supply of multiple vaccines to the UK government in its fight against COVID19, including AZD1222, the vaccine co-invented by the University of Oxford and its spinout company, Vaccitech, and licensed by AstraZeneca," the company said.2) Tata Motors reported better than expected Q1 results. Tata JLR EBITDA and EBITDA margin ahead of expectation. Company reported consol revenues declined ~48% YoY to Rs32000cr (expectation Rs25400cr), Consol EBITDA declined 79% YoY to Rs640cr – expectation loss Rs3010cr, Consol Adj. Net loss at Rs8380cr vs estimates Rs9800cr. JLR net realizations grew 20% YoY (+28% QoQ) to GBP58.5k (v/s est GBP49.2k). JLR net revenues declined 44% YoY to GBP2.9b (v/s est GBP2.4b). JLR EBITDA margins at 3.5% (-70bp YoY, -130bp QoQ, v/s est -3.6%). Beat on EBITDA was driven by a strong mix and cost cutting of GBP500m. S/A business revenues declined 80% YoY to Rs2670cr (v/s estimates Rs2240cr), EBITDA loss at Rs700cr vs estimates loss Rs1170cr & Net loss of Rs2140cr vs Rs2550cr. &Wockhardt #MOMarketUpdates #Indiastockmarket #Tatamotors #Nifty50 #NSE #BSE #Nifty #Sensex

1. Tata Coffee Ltd on Tuesday reported a 77% increase in consolidated net profit at Rs 62 crore for the quarter ended June. Its net profit stood at Rs 35 crore in the year-ago period. Consolidated total income for the quarter higher at Rs 592 crore compared to Rs 472 crore for the corresponding quarter of the previous year, an increase of 26%, driven by improved performance from the value-added businesses.2. Pharma major Dr Reddy recorded smart rally after the company reported strong Q1 results. The company reported impressive revenue growth in European and North America. #MOMarketUpdates #DrReddy #TATACoffee #MotilalOswal #Companyresults #indianstockmarket #NSE #BSE #Nifty #Sensex